Table 6 Outcomes of infections due to carbapenem-resistant Enterobacteriaceae by type of infection
Outcome | Number (%) of patients | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Infection type | |||||||||
VABP (N = 31) | Bacteremia (N = 22) | cUTI/AP (N = 18) | HABP (N = 16) | SWI (N = 16) | BTI (N = 9) | DWI (N = 7) | SBFI (N = 5) | All (N = 124) | |
Duration of hospitalization for CRE infectiona (mean ± SD) | 15.8 (14.3) | 14.6 (7.9) | 6.7 (9.4) | 10.5 (4.5) | 9.3 (3.2) | 7.6 (5.4) | 8.3 (4.9) | 10.4 (2.1) | 11.3 (9.7) |
Duration of ICU staya (mean ± SD) | 8.4 (6.9) | 9.2 (8.4) | 2.3 (3.9) | 3.5 (2.9) | 1.7 (4.4) | 1.9 (2.4) | 2.4 (2.4) | 2.0 (2.8) | 5.1 (4.2) |
Clinical cure, n (%) | |||||||||
Yes | 18 (58.1%) | 10 (45.5%) | 16 (88.9%) | 11 (68.8%) | 15 (93.8%) | 9 (100%) | 5 (71.4%) | 4 (80.0%) | 88 (71.0%) |
No | 11 (35.5%) | 11 (50.0%) | 2 (11.1%) | 4 (25.0%) | 1 (6.3%) | 0 | 1 (14.3%) | 1 (20.0%) | 30 (24.2%) |
Unknown | 2 (6.5%) | 1 (4.5%) | 0 | 1 (6.3%) | 0 | 0 | 1 (14.3%) | 0 | 6 (4.8%) |
CRE eradicated, n (%) | |||||||||
Yes | 15 (48.4%) | 12 (54.5%) | 16 (88.9%) | 10 (62.5%) | 10 (62.5%) | 9 (100%) | 5 (71.4%) | 4 (80.0%) | 81 (65.3%) |
No | 12 (38.7%) | 9 (40.9%) | 1 (5.6%) | 4 (25.0%) | 6 (37.5%) | 0 | 1 (14.3%) | 1 (20.0%) | 34 (27.4%) |
Unknown | 4 (12.9%) | 1 (4.5%) | 1 (5.6%) | 2 (12.5%) | 0 | 0 | 1 (14.3%) | 0 | 9 (7.3%) |
28-day mortality, n (%) | |||||||||
Yes | 10 (32.3%) | 10 (45.5%) | 1 (5.6%) | 4 (25.0%) | 1 (6.3%) | 0 | 1 (14.3%) | 1 (20.0%) | 28 (22.6%) |
No | 19 (61.3%) | 11 (50.0%) | 17 (94.4%) | 10 (62.5%) | 15 (93.8%) | 9 (100%) | 5 (71.4%) | 4 (80.0%) | 90 (72.6%) |
Unknown | 2 (6.5%) | 1 (4.5%) | 0 | 2 (12.5%) | 0 | 0 | 1 (14.3%) | 0 | 6 (4.8%) |